Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Finished Goods (2024 - 2025)

Hinge Health (HNGE) has disclosed Finished Goods for 2 consecutive years, with $9.0 million as the latest value for Q4 2025.

  • Quarterly Finished Goods rose 117.05% to $9.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.0 million through Dec 2025, up 117.05% year-over-year, with the annual reading at $9.0 million for FY2025, 117.05% up from the prior year.
  • Finished Goods hit $9.0 million in Q4 2025 for Hinge Health, up from $6.7 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $9.0 million in Q4 2025 to a low of $4.1 million in Q4 2024.